BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+15.53%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.52B
AUM Growth
+$1.52B
(+21%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
46.09%
Holding
98
New
17
Increased
26
Reduced
19
Closed
7
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$22.6M |
| 2 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$20.8M |
| 3 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$17.2M |
| 4 |
Zevra Therapeutics
ZVRA
|
$15.2M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$13.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.7M |
| 2 |
Travere Therapeutics
TVTX
|
$26.5M |
| 3 |
Heron Therapeutics
HRTX
|
$12.8M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
$12.5M |
| 5 |
UAM
Universal American Corp
UAM
|
$12.1M |
Sector Composition
| 1 | Healthcare | 92.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $167M | 8.99% | 4,815,807 -2,237,697 | -32% | -$77.7M |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.43B
| $105M | 5.67% | 4,975,184 +255,225 | +5% | +$5.41M |
|
|
3
Heron Therapeutics
HRTX
$207M
| $74.7M | 4.01% | 2,396,681 -411,492 | -15% | -$12.8M |
|
|
4
Travere Therapeutics
TVTX
$1.56B
| $71.7M | 3.85% | 2,162,928 -799,370 | -27% | -$26.5M |
|
|
PGNX
5
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $66.8M | 3.59% | 8,951,169 | – | – |
|
6
Emergent Biosolutions
EBS
$443M
| $58M | 3.12% | 1,760,519 -50,000 | -3% | -$1.65M |
|
|
AEGR
7
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $54.1M | 2.91% | 2,852,578 +350,000 | +14% | +$6.64M |
|
8
AngioDynamics
ANGO
$417M
| $39.3M | 2.11% | 2,398,527 | – | – |
|
|
RXDX
9
DELISTED
Ignyta, Inc.
RXDX
| $34.1M | 1.83% | 2,256,546 +514,846 | +30% | +$7.77M |
|
|
PTX
10
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $30M | 1.61% | 5,075,929 +2,907,603 | +134% | +$17.2M |
|
|
ADXS
11
DELISTED
Advaxis, Inc.
ADXS
| $29.5M | 1.58% | 1,450,094 +644,100 | +80% | +$13.1M |
|
|
BDSI
12
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $28.2M | 1.52% | 3,544,060 +1,297,661 | +58% | +$10.3M |
|
13
Assertio
ASRT
$80.4M
| $25.1M | 1.35% | 1,167,442 +462,238 | +66% | +$9.92M |
|
|
14
Amphastar Pharmaceuticals
AMPH
$1.42B
| $24.9M | 1.34% | 1,417,956 -709,898 | -33% | -$12.5M |
|
|
ALR
15
DELISTED
Alere Inc
ALR
| $23.9M | 1.28% | 452,423 | – | – |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $22.6M | 1.21% | +419,559 | New | +$22.6M |
|
|
ACGN
17
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $21M | 1.13% | 5,663,845 | – | – |
|
|
RPTP
18
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $20.8M | 1.12% | +1,319,883 | New | +$20.8M |
|
|
CORI
19
DELISTED
Corium International, Inc.
CORI
| $20.6M | 1.11% | 1,504,762 -231,974 | -13% | -$3.18M |
|
20
Rigel Pharmaceuticals
RIGL
$697M
| $18.9M | 1.01% | 5,876,752 -2,369,577 | -29% | -$7.61M |
|
|
LJPC
21
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $18.6M | 1% | 759,470 +56,000 | +8% | +$1.37M |
|
|
QLTI
22
DELISTED
QLT Inc
QLTI
| $18.4M | 0.99% | 4,445,527 +3,300,000 | +288% | +$13.6M |
|
|
SCTL
23
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $18.3M | 0.98% | 1,413,533 | – | – |
|
|
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $18.1M | 0.97% | 2,650,000 +1,850,000 | +231% | +$12.7M |
|
|
ZGNX
25
DELISTED
Zogenix, Inc.
ZGNX
| $18M | 0.97% | 10,737,645 | – | – |
|